bexovid
Commercial- Indications
- Antiviral
Company intelligence / Profile preview
Beximco Pharmaceuticals is a leading manufacturer and exporter of medicines in Bangladesh with products sold in over 50 countries including highly regulated markets like the USA, Europe, Canada, and Australia. In 2020, they introduced the world's first generic remdesivir for COVID-19 treatment and became the first company to obtain production and marketing authorization for molnupiravir in Bangladesh.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beximco Pharmaceuticals Ltd.